IBRX logo

ImmunityBio (IBRX) Net income

annual net income:

-$413.56M+$169.63M(+29.09%)
December 31, 2024

Summary

  • As of today (June 29, 2025), IBRX annual net profit is -$413.56 million, with the most recent change of +$169.63 million (+29.09%) on December 31, 2024.
  • During the last 3 years, IBRX annual net income has fallen by -$66.77 million (-19.25%).
  • IBRX annual net income is now -162.12% below its all-time high of -$157.78 million, reached on December 31, 2019.

Performance

IBRX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXincome statement metrics

quarterly net income:

-$129.65M-$70.48M(-119.14%)
March 31, 2025

Summary

  • As of today (June 29, 2025), IBRX quarterly net profit is -$129.65 million, with the most recent change of -$70.48 million (-119.14%) on March 31, 2025.
  • Over the past year, IBRX quarterly net income has increased by +$4.46 million (+3.33%).
  • IBRX quarterly net income is now -250.04% below its all-time high of -$37.04 million, reached on March 31, 2020.

Performance

IBRX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXincome statement metrics

TTM net income:

-$409.10M+$4.46M(+1.08%)
March 31, 2025

Summary

  • As of today (June 29, 2025), IBRX TTM net profit is -$409.10 million, with the most recent change of +$4.46 million (+1.08%) on March 31, 2025.
  • Over the past year, IBRX TTM net income has increased by +$191.86 million (+31.93%).
  • IBRX TTM net income is now -1004.54% below its all-time high of -$37.04 million, reached on March 31, 2020.

Performance

IBRX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

IBRX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.1%+3.3%+31.9%
3 y3 years-19.3%-26.1%-10.6%
5 y5 years-162.1%-250.0%-1004.5%

IBRX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-19.3%+29.1%-119.1%+44.5%-10.6%+31.9%
5 y5-year-162.1%+29.1%-250.0%+44.5%-1004.5%+31.9%
alltimeall time-162.1%+29.1%-250.0%+44.5%-1004.5%+31.9%

IBRX Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$129.65M(+119.1%)
-$409.10M(-1.1%)
Dec 2024
-$413.56M(-29.1%)
-$59.16M(-31.0%)
-$413.56M(-29.6%)
Sep 2024
-
-$85.73M(-36.3%)
-$587.79M(-1.6%)
Jun 2024
-
-$134.56M(+0.3%)
-$597.65M(-0.6%)
Mar 2024
-
-$134.11M(-42.5%)
-$600.96M(+3.0%)
Dec 2023
-$583.20M(+40.0%)
-$233.39M(+144.2%)
-$583.20M(+27.3%)
Sep 2023
-
-$95.58M(-30.7%)
-$458.02M(-3.2%)
Jun 2023
-
-$137.88M(+18.5%)
-$473.38M(+10.1%)
Mar 2023
-
-$116.34M(+7.5%)
-$430.08M(+3.2%)
Dec 2022
-$416.57M
-$108.22M(-2.5%)
-$416.57M(+4.2%)
Sep 2022
-
-$110.94M(+17.3%)
-$399.61M(+6.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$94.59M(-8.0%)
-$376.30M(+1.7%)
Mar 2022
-
-$102.83M(+12.7%)
-$370.00M(+6.7%)
Dec 2021
-$346.79M(+56.3%)
-$91.26M(+4.1%)
-$346.79M(+7.3%)
Sep 2021
-
-$87.63M(-0.7%)
-$323.30M(+7.3%)
Jun 2021
-
-$88.29M(+10.9%)
-$301.28M(+13.9%)
Mar 2021
-
-$79.61M(+17.5%)
-$264.43M(+19.2%)
Dec 2020
-$221.85M(+40.6%)
-$67.77M(+3.3%)
-$221.85M(+44.0%)
Sep 2020
-
-$65.60M(+27.5%)
-$154.08M(+74.1%)
Jun 2020
-
-$51.44M(+38.9%)
-$88.48M(+138.9%)
Mar 2020
-
-$37.04M
-$37.04M
Dec 2019
-$157.78M
-
-

FAQ

  • What is ImmunityBio annual net profit?
  • What is the all time high annual net income for ImmunityBio?
  • What is ImmunityBio annual net income year-on-year change?
  • What is ImmunityBio quarterly net profit?
  • What is the all time high quarterly net income for ImmunityBio?
  • What is ImmunityBio quarterly net income year-on-year change?
  • What is ImmunityBio TTM net profit?
  • What is the all time high TTM net income for ImmunityBio?
  • What is ImmunityBio TTM net income year-on-year change?

What is ImmunityBio annual net profit?

The current annual net income of IBRX is -$413.56M

What is the all time high annual net income for ImmunityBio?

ImmunityBio all-time high annual net profit is -$157.78M

What is ImmunityBio annual net income year-on-year change?

Over the past year, IBRX annual net profit has changed by +$169.63M (+29.09%)

What is ImmunityBio quarterly net profit?

The current quarterly net income of IBRX is -$129.65M

What is the all time high quarterly net income for ImmunityBio?

ImmunityBio all-time high quarterly net profit is -$37.04M

What is ImmunityBio quarterly net income year-on-year change?

Over the past year, IBRX quarterly net profit has changed by +$4.46M (+3.33%)

What is ImmunityBio TTM net profit?

The current TTM net income of IBRX is -$409.10M

What is the all time high TTM net income for ImmunityBio?

ImmunityBio all-time high TTM net profit is -$37.04M

What is ImmunityBio TTM net income year-on-year change?

Over the past year, IBRX TTM net profit has changed by +$191.86M (+31.93%)
On this page